Summit Wealth & Retirement Planning’s Medifast MED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-2,238
Closed -$404K – 113
2022
Q2
$404K Sell
2,238
-50
-2% -$8.95K 0.16% 74
2022
Q1
$391K Sell
2,288
-116
-5% -$21.9K 0.14% 76
2021
Q4
$503K Sell
2,404
-155
-6% -$32K 0.17% 60
2021
Q3
$493K Sell
2,559
-331
-11% -$81.4K 0.18% 60
2021
Q2
$818K Sell
2,890
-144
-5% -$39K 0.3% 51
2021
Q1
$643K Sell
3,034
-1,367
-31% -$327K 0.24% 65
2020
Q4
$864K Buy
+4,401
New +$778K 0.33% 59

Other funds holding MED

Summit Wealth & Retirement Planning's MED Position: Q3 2022 in Review

Summit Wealth & Retirement Planning sold out of Medifast (MED) in Q3 2022, closing a stake of 2,238 shares — an estimated $404K sold.

Summit Wealth & Retirement Planning first reported a position in MED in Q4 2020 and held it in 7 quarters. The position peaked at $864K in Q4 2020. 263 funds tracked by Wall St. Rank hold MED as of Q3 2022.

  • Summit Wealth & Retirement Planning reported no remaining Medifast position as of Q3 2022 after selling out during the quarter.
  • Summit Wealth & Retirement Planning sold 2,238 Medifast shares in Q3 2022, an estimated $404K.
  • Summit Wealth & Retirement Planning first reported a position in Medifast in Q4 2020 and held it in 7 quarters.
  • Summit Wealth & Retirement Planning's Medifast position peaked at $864K in Q4 2020.
  • 263 funds tracked by Wall St. Rank held Medifast as of Q3 2022.

Based on Summit Wealth & Retirement Planning's 13F filing for Q3 2022, filed 14 Nov 2022.